Physician profile
Robert E Nugent
NPI 1003344219
$16,420.50
in general payments reported to CMS, 2019-2025
13 companies · $288 in 2025
The $288 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $8,322 · 2023: $7,681 · 2024: $130 · 2025: $288.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,171 · Food and Beverage: $928.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,170.99 |
| Food and Beverage | $927.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $13,373.05 | 2022-2024 | Evos, Trigen Intertan, Pico 14 |
| Microport Orthopedics INC | $1,524.92 | 2022 | |
| Zimmer Biomet Holdings, INC. | $698.95 | 2022-2023 | Persona, Avenir |
| Stryker Corporation | $370.57 | 2023-2025 | Mako, Triathlon, Gamma |
| Depuy Synthes Sales INC. | $143.49 | 2023 | Attune |
| Medacta USA, INC. | $62.00 | 2024 | |
| Heraeus Medical, LLC. | $57.35 | 2025 | |
| Organogenesis INC. | $48.59 | 2025 | Puraply Wound Matrix |
| Averitas Pharma INC. | $41.60 | 2025 | Qutenza |
| Mimedx Group, INC. | $29.35 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $28.74 | 2025 | Exparel |
| Nevro Corp. | $28.08 | 2024 | Senza |
| Linkbio Corp | $13.81 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Nugent listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.